Evidence map›Paper›PMID 25099287›Full record

ArticleScientific reports2014

p27 kip1 haplo-insufficiency improves cardiac function in early-stages of myocardial infarction by protecting myocardium and increasing angiogenesis by promoting IKK activation.

Ningtian Zhou, Yuxuan Fu, Yunle Wang, Pengsheng Chen, Haoyu Meng, Shouyu Guo, Min Zhang, Zhijian Yang, Yingbin Ge

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Signaling Pathways in Cardiac Myocyte Apoptosis.BioMed research international · 2016
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ningtian ZhouDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Yuxuan FuDepartment of Physiology, Nanjing Medical University, Nanjing, People's Republic of China.
Yunle WangDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Pengsheng ChenDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Haoyu MengDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Shouyu GuoDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Min ZhangDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Zhijian YangDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Yingbin GeDepartment of Physiology, Nanjing Medical University, Nanjing, People's Republic of China.
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

p27(kip1) (p27) is widely known as a potent cell cycle inhibitor in several organs, especially in the heart. However, its role has not been fully defined during the early phase of myocardial infarction (MI). In this study, we investigated the relationships between p27, vascular endothelial growth factor/hepatocyte growth factor (VEGF/HGF) and NF-κB in post-MI cardiac function repair both in vivo and in the hypoxia/ischemia-induced rat myocardiocyte model. In vivo, haplo-insufficiency of p27 improved cardiac function, diminished the infarct zone, protected myocardiocytes and increased angiogenesis by enhancing the production of VEGF/HGF. In vitro, the presence of conditioned medium from hypoxia/ischemia-induced p27 knockdown myocardiocytes reduced the injury caused by hypoxia/ischemia in myocardiocytes, and this effect was reversed by VEGF/HGF neutralizing antibodies, consistent with the cardioprotection being due to VEGF/HGF secretion. We also observed that p27 bound to IKK and that p27 haplo-insufficiency promoted IKK/p65 activation both in vivo and in vitro, thereby inducing the NF-κB downstream regulator, VEGF/HGF. Furthermore, IKKi and IKK inhibitor negated the effect of VEGF/HGF. Therefore, we conclude that p27 haplo-insufficiency protects against heart injury by VEGF/HGF mediated cardioprotection and increased angiogenesis through promoting IKK activation.

Indexed as

HaploinsufficiencyNeovascularization, PhysiologicAnimalsAntibodies, NeutralizingCell HypoxiaCell LineCulture Media, ConditionedCyclin-Dependent Kinase Inhibitor p27Endothelium, VascularEnzyme ActivationGene Expression RegulationGene Knockdown TechniquesHaplotypesHepatocyte Growth FactorI-kappa B KinaseMaleAntibodies, NeutralizingCulture Media, ConditionedCyclin-Dependent Kinase Inhibitor p27Hepatocyte Growth FactorI-kappa B KinaseNF-kappa BVascular Endothelial Growth Factor Avascular endothelial growth factor A, rat

Identifiers

PMID25099287
PMCPMC4124466
OpenAlexW2091727170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.